Want to add your organization’s event to the calendar? Click here to Submit Your Event.
- This event has passed.
New Maryland/Israel Collaborations in Biotech, Pharma and AI
Hear from cutting edge Maryland and Israeli companies and how their technologies and innovative solutions are transforming several industries.
Featuring:
– Jonathan Cohen, President & CEO, 20/20 GeneSystems, a clinical laboratory testing company for bio-testing, COVID, and cancer diagnostic tools.
– Amichai Glattstein, CEO, IDenta Corp, Detection Solutions for Drugs, Explosives and Unique Forensic Products for Government and Consumer Customers.
– Kari Stoever, Chief External Relations Officer, On Demand Pharmaceuticals, an innovative technology company transforming how medicines are made.
– Ilan Avni, Head Global Business Development & Marketing, Wavelength Pharmaceuticals, a world-class developer and manufacturer of active pharmaceuticals ingredients.
– Nir Gamliel, Chief Business Officer, OpenDNA, precision genomic, AI, and Machine Learning to predict and prevent chronic diseases.
– Andrea Yonah, Director of Business Development, BIRD Foundation, on grant funding and collaborative opportunities for Maryland and Israeli companies.
Moderator, Stuart S. Kurlander, Partner, Healthcare and Life Sciences in Latham & Watkins’ Washington, D.C. office and Global Co-Chair of the Israel Practice.
To register: https://MIDCnewcollaborations.eventbrite.com